mBio (Jun 2021)
Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs
Abstract
R-pyocins have potential as alternative therapeutics against Pseudomonas aeruginosaP. aeruginosaP. aeruginosa